Cargando…

The Target Residence Time of Antihistamines Determines Their Antagonism of the G Protein-Coupled Histamine H1 Receptor

The pharmacodynamics of drug-candidates is often optimized by metrics that describe target binding (K(d) or K(i) value) or target modulation (IC(50)). However, these metrics are determined at equilibrium conditions, and consequently information regarding the onset and offset of target engagement and...

Descripción completa

Detalles Bibliográficos
Autores principales: Bosma, Reggie, Witt, Gesa, Vaas, Lea A. I., Josimovic, Ivana, Gribbon, Philip, Vischer, Henry F., Gul, Sheraz, Leurs, Rob
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5627017/
https://www.ncbi.nlm.nih.gov/pubmed/29033838
http://dx.doi.org/10.3389/fphar.2017.00667
_version_ 1783268638969561088
author Bosma, Reggie
Witt, Gesa
Vaas, Lea A. I.
Josimovic, Ivana
Gribbon, Philip
Vischer, Henry F.
Gul, Sheraz
Leurs, Rob
author_facet Bosma, Reggie
Witt, Gesa
Vaas, Lea A. I.
Josimovic, Ivana
Gribbon, Philip
Vischer, Henry F.
Gul, Sheraz
Leurs, Rob
author_sort Bosma, Reggie
collection PubMed
description The pharmacodynamics of drug-candidates is often optimized by metrics that describe target binding (K(d) or K(i) value) or target modulation (IC(50)). However, these metrics are determined at equilibrium conditions, and consequently information regarding the onset and offset of target engagement and modulation is lost. Drug-target residence time is a measure for the lifetime of the drug-target complex, which has recently been receiving considerable interest, as target residence time is shown to have prognostic value for the in vivo efficacy of several drugs. In this study, we have investigated the relation between the increased residence time of antihistamines at the histamine H(1) receptor (H(1)R) and the duration of effective target-inhibition by these antagonists. Hela cells, endogenously expressing low levels of the H(1)R, were incubated with a series of antihistamines and dissociation was initiated by washing away the unbound antihistamines. Using a calcium-sensitive fluorescent dye and a label free, dynamic mass redistribution based assay, functional recovery of the H(1)R responsiveness was measured by stimulating the cells with histamine over time, and the recovery was quantified as the receptor recovery time. Using these assays, we determined that the receptor recovery time for a set of antihistamines differed more than 40-fold and was highly correlated to their H(1)R residence times, as determined with competitive radioligand binding experiments to the H(1)R in a cell homogenate. Thus, the receptor recovery time is proposed as a cell-based and physiologically relevant metric for the lead optimization of G protein-coupled receptor antagonists, like the H(1)R antagonists. Both, label-free or real-time, classical signaling assays allow an efficient and physiologically relevant determination of kinetic properties of drug molecules.
format Online
Article
Text
id pubmed-5627017
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-56270172017-10-13 The Target Residence Time of Antihistamines Determines Their Antagonism of the G Protein-Coupled Histamine H1 Receptor Bosma, Reggie Witt, Gesa Vaas, Lea A. I. Josimovic, Ivana Gribbon, Philip Vischer, Henry F. Gul, Sheraz Leurs, Rob Front Pharmacol Pharmacology The pharmacodynamics of drug-candidates is often optimized by metrics that describe target binding (K(d) or K(i) value) or target modulation (IC(50)). However, these metrics are determined at equilibrium conditions, and consequently information regarding the onset and offset of target engagement and modulation is lost. Drug-target residence time is a measure for the lifetime of the drug-target complex, which has recently been receiving considerable interest, as target residence time is shown to have prognostic value for the in vivo efficacy of several drugs. In this study, we have investigated the relation between the increased residence time of antihistamines at the histamine H(1) receptor (H(1)R) and the duration of effective target-inhibition by these antagonists. Hela cells, endogenously expressing low levels of the H(1)R, were incubated with a series of antihistamines and dissociation was initiated by washing away the unbound antihistamines. Using a calcium-sensitive fluorescent dye and a label free, dynamic mass redistribution based assay, functional recovery of the H(1)R responsiveness was measured by stimulating the cells with histamine over time, and the recovery was quantified as the receptor recovery time. Using these assays, we determined that the receptor recovery time for a set of antihistamines differed more than 40-fold and was highly correlated to their H(1)R residence times, as determined with competitive radioligand binding experiments to the H(1)R in a cell homogenate. Thus, the receptor recovery time is proposed as a cell-based and physiologically relevant metric for the lead optimization of G protein-coupled receptor antagonists, like the H(1)R antagonists. Both, label-free or real-time, classical signaling assays allow an efficient and physiologically relevant determination of kinetic properties of drug molecules. Frontiers Media S.A. 2017-09-25 /pmc/articles/PMC5627017/ /pubmed/29033838 http://dx.doi.org/10.3389/fphar.2017.00667 Text en Copyright © 2017 Bosma, Witt, Vaas, Josimovic, Gribbon, Vischer, Gul and Leurs. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Pharmacology
Bosma, Reggie
Witt, Gesa
Vaas, Lea A. I.
Josimovic, Ivana
Gribbon, Philip
Vischer, Henry F.
Gul, Sheraz
Leurs, Rob
The Target Residence Time of Antihistamines Determines Their Antagonism of the G Protein-Coupled Histamine H1 Receptor
title The Target Residence Time of Antihistamines Determines Their Antagonism of the G Protein-Coupled Histamine H1 Receptor
title_full The Target Residence Time of Antihistamines Determines Their Antagonism of the G Protein-Coupled Histamine H1 Receptor
title_fullStr The Target Residence Time of Antihistamines Determines Their Antagonism of the G Protein-Coupled Histamine H1 Receptor
title_full_unstemmed The Target Residence Time of Antihistamines Determines Their Antagonism of the G Protein-Coupled Histamine H1 Receptor
title_short The Target Residence Time of Antihistamines Determines Their Antagonism of the G Protein-Coupled Histamine H1 Receptor
title_sort target residence time of antihistamines determines their antagonism of the g protein-coupled histamine h1 receptor
topic Pharmacology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5627017/
https://www.ncbi.nlm.nih.gov/pubmed/29033838
http://dx.doi.org/10.3389/fphar.2017.00667
work_keys_str_mv AT bosmareggie thetargetresidencetimeofantihistaminesdeterminestheirantagonismofthegproteincoupledhistamineh1receptor
AT wittgesa thetargetresidencetimeofantihistaminesdeterminestheirantagonismofthegproteincoupledhistamineh1receptor
AT vaasleaai thetargetresidencetimeofantihistaminesdeterminestheirantagonismofthegproteincoupledhistamineh1receptor
AT josimovicivana thetargetresidencetimeofantihistaminesdeterminestheirantagonismofthegproteincoupledhistamineh1receptor
AT gribbonphilip thetargetresidencetimeofantihistaminesdeterminestheirantagonismofthegproteincoupledhistamineh1receptor
AT vischerhenryf thetargetresidencetimeofantihistaminesdeterminestheirantagonismofthegproteincoupledhistamineh1receptor
AT gulsheraz thetargetresidencetimeofantihistaminesdeterminestheirantagonismofthegproteincoupledhistamineh1receptor
AT leursrob thetargetresidencetimeofantihistaminesdeterminestheirantagonismofthegproteincoupledhistamineh1receptor
AT bosmareggie targetresidencetimeofantihistaminesdeterminestheirantagonismofthegproteincoupledhistamineh1receptor
AT wittgesa targetresidencetimeofantihistaminesdeterminestheirantagonismofthegproteincoupledhistamineh1receptor
AT vaasleaai targetresidencetimeofantihistaminesdeterminestheirantagonismofthegproteincoupledhistamineh1receptor
AT josimovicivana targetresidencetimeofantihistaminesdeterminestheirantagonismofthegproteincoupledhistamineh1receptor
AT gribbonphilip targetresidencetimeofantihistaminesdeterminestheirantagonismofthegproteincoupledhistamineh1receptor
AT vischerhenryf targetresidencetimeofantihistaminesdeterminestheirantagonismofthegproteincoupledhistamineh1receptor
AT gulsheraz targetresidencetimeofantihistaminesdeterminestheirantagonismofthegproteincoupledhistamineh1receptor
AT leursrob targetresidencetimeofantihistaminesdeterminestheirantagonismofthegproteincoupledhistamineh1receptor